My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 539

    1.

    Effects of dietary treatment alone or diet with voglibose or glyburide on abdominal adipose tissue and metabolic abnormalities in patients with newly diagnosed type 2 diabetes.

    Takami K, Takeda N, Nakashima K, Takami R, Hayashi M, Ozeki S, Yamada A, Kokubo Y, Sato M, Kawachi S, Sasaki A, Yasuda K.

    Diabetes Care. 2002 Apr;25(4):658-62.PMID: 11919121 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effects of voglibose on glycemic excursions, insulin secretion, and insulin sensitivity in non-insulin-treated NIDDM patients.

    Matsumoto K, Yano M, Miyake S, Ueki Y, Yamaguchi Y, Akazawa S, Tominaga Y.

    Diabetes Care. 1998 Feb;21(2):256-60.PMID: 9539992 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effect of troglitazone on body fat distribution in type 2 diabetic patients.

    Mori Y, Murakawa Y, Okada K, Horikoshi H, Yokoyama J, Tajima N, Ikeda Y.

    Diabetes Care. 1999 Jun;22(6):908-12.PMID: 10372240 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone.

    Miyazaki Y, Mahankali A, Matsuda M, Glass L, Mahankali S, Ferrannini E, Cusi K, Mandarino LJ, DeFronzo RA.

    Diabetes Care. 2001 Apr;24(4):710-9.PMID: 11315836 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    The effect of high- and low-glycemic index energy restricted diets on plasma lipid and glucose profiles in type 2 diabetic subjects with varying glycemic control.

    Heilbronn LK, Noakes M, Clifton PM.

    J Am Coll Nutr. 2002 Apr;21(2):120-7.PMID: 11999539 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Bromocriptine: a novel approach to the treatment of type 2 diabetes.

    Pijl H, Ohashi S, Matsuda M, Miyazaki Y, Mahankali A, Kumar V, Pipek R, Iozzo P, Lancaster JL, Cincotta AH, DeFronzo RA.

    Diabetes Care. 2000 Aug;23(8):1154-61.PMID: 10937514 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).

    Davis TM, Cull CA, Holman RR; U.K. Prospective Diabetes Study (UKPDS) Group.

    Diabetes Care. 2001 Jul;24(7):1167-74.PMID: 11423497 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Comparison of different insulin regimens in elderly patients with NIDDM.

    Wolffenbuttel BH, Sels JP, Rondas-Colbers GJ, Menheere PP, Nieuwenhuijzen Kruseman AC.

    Diabetes Care. 1996 Dec;19(12):1326-32.PMID: 8941458 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes.

    Hirose H, Kawai T, Yamamoto Y, Taniyama M, Tomita M, Matsubara K, Okazaki Y, Ishii T, Oguma Y, Takei I, Saruta T.

    Metabolism. 2002 Mar;51(3):314-7.PMID: 11887166 [PubMed - indexed for MEDLINE]Related articles

    10.

    Efficacy of 24-week monotherapy with acarbose, glibenclamide, or placebo in NIDDM patients. The Essen Study.

    Hoffmann J, Spengler M.

    Diabetes Care. 1994 Jun;17(6):561-6.PMID: 8082525 [PubMed - indexed for MEDLINE]Related articles

    11.

    Threshold values of visceral fat measures and their anthropometric alternatives for metabolic derangement in Japanese obese boys.

    Asayama K, Dobashi K, Hayashibe H, Kodera K, Uchida N, Nakane T, Araki T, Nakazawa S.

    Int J Obes Relat Metab Disord. 2002 Feb;26(2):208-13.PMID: 11850752 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises.

    Umpierrez GE, Clark WS, Steen MT.

    Diabetes Care. 1997 Apr;20(4):479-83.PMID: 9096964 [PubMed - indexed for MEDLINE]Related articles

    13.

    Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.

    Nam SY, Kim KR, Cha BS, Song YD, Lim SK, Lee HC, Huh KB.

    Int J Obes Relat Metab Disord. 2001 Aug;25(8):1101-7.PMID: 11477493 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance.

    Kelley DE, Thaete FL, Troost F, Huwe T, Goodpaster BH.

    Am J Physiol Endocrinol Metab. 2000 May;278(5):E941-8.PMID: 10780952 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetes.

    Miyazaki Y, Matsuda M, DeFronzo RA.

    Diabetes Care. 2002 Mar;25(3):517-23.PMID: 11874940 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women.

    DeNino WF, Tchernof A, Dionne IJ, Toth MJ, Ades PA, Sites CK, Poehlman ET.

    Diabetes Care. 2001 May;24(5):925-32.PMID: 11347756 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Separate associations between visceral and subcutaneous adipose tissue distribution, insulin and glucose levels in obese women.

    Ross R, Fortier L, Hudson R.

    Diabetes Care. 1996 Dec;19(12):1404-11.PMID: 8941472 [PubMed - indexed for MEDLINE]Related articles

    18.

    The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM.

    Markovic TP, Jenkins AB, Campbell LV, Furler SM, Kraegen EW, Chisholm DJ.

    Diabetes Care. 1998 May;21(5):687-94.PMID: 9589225 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Lipoprotein subfraction composition in non-obese newly diagnosed non-insulin dependent diabetes after treatment with diet and glibenclamide.

    Billingham MS, Milles JJ, Bailey CJ, Hall RA.

    Diabetes Res. 1989 May;11(1):13-20.PMID: 2515931 [PubMed - indexed for MEDLINE]Related articles

    20.

    Management of newly diagnosed non-insulin-dependent (type 2) diabetes mellitus: a retrospective audit.

    Marsiaj HI, Catalano C, Sum CF, Home PD, Alberti KG.

    Diabetes Res Clin Pract. 1991 May;12(2):129-36.PMID: 1879304 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity